Lv645
3058 积分 2024-09-24 加入
Discovery of a Hydroxamic Acid-Based HDAC11 Isoform-Selective Inhibitor with Oral Anti-AML Potency
5小时前
已完结
Deciphering the Comprehensive Structure–Activity Relationship of Sunshinamide for Breast Cancer Therapy through Dual Modulation of Apoptotic and Ferroptotic Pathways via TrxR1 and Gpx4 Inhibition
5小时前
已完结
Discovery of Potent Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) Inhibitors with Antiferroptotic Properties
5小时前
已完结
Discovery of noncovalent diaminopyrimidine-based Inhibitors for glioblastoma via a dual FAK/DNA targeting strategy
8天前
已完结
Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors
2个月前
已完结
2019 FDA drug approvals
2个月前
已完结
Discovery and Development of the Oral Complement Factor D Inhibitor Danicopan (ACH-4471)
2个月前
已完结
2018 FDA drug approvals
2个月前
已完结
2019 FDA drug approvals
2个月前
已完结
Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy
4个月前
已完结
皖公网安备34019202002308
